Adaptimmune Therapeutics PLC
Adaptimmune Therapeutics PLC (ADAP) is a publicly traded company in the Unknown sector. Across all available filings, 30 corporate insiders have executed 230 transactions totaling $574.4M, demonstrating a bullish sentiment with $479.5M in net insider flow. The most recent transaction on Sep 2, 2025 involved a sale of 96,000 shares valued at $960.
ADAP Insider Activity Summary
Who Is Buying ADAP Stock?
No significant insider buying has been recorded for ADAP in the recent period.
Who Is Selling ADAP Stock?
No significant insider selling has been recorded for ADAP in the recent period.
Is Adaptimmune Therapeutics PLC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ADAP is bullish with an Insider Alignment Score of 92/100 and a net flow of $479.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ADAP Frequently Asked Questions
Understanding ADAP Insider Activity
Insider trading at Adaptimmune Therapeutics PLC (ADAP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 30 insiders are actively trading ADAP stock, having executed 230 transactions in the past 90 days. The most active insider is Forest Baskett (Executive), who has made 9 transactions totaling $54.1M.
Related Tools
Track Adaptimmune Therapeutics PLC Insider Activity
Get notified when executives and directors at ADAP file new Form 4 transactions